Nkarta, Inc. - Common Stock (NKTX)
2.3400
-0.0200 (-0.85%)
Nkarta Inc is a biotechnology company focused on the development of novel cell therapies to treat cancer
The company specializes in engineering natural killer (NK) cells, which are a type of immune cell known for their ability to recognize and destroy tumors. Nkarta aims to harness the power of these cells to create innovative, targeted therapies that can enhance the body's immune response against various forms of cancer. Through its research and clinical development efforts, Nkarta seeks to provide meaningful treatment options for patients facing challenging malignancies.
Frequently Asked Questions
Is Nkarta, Inc. - Common Stock publicly traded?
Yes, Nkarta, Inc. - Common Stock is publicly traded.
What exchange does Nkarta, Inc. - Common Stock trade on?
Nkarta, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Nkarta, Inc. - Common Stock?
The ticker symbol for Nkarta, Inc. - Common Stock is NKTX on the Nasdaq Stock Market
What is the current price of Nkarta, Inc. - Common Stock?
The current price of Nkarta, Inc. - Common Stock is 2.340
When was Nkarta, Inc. - Common Stock last traded?
The last trade of Nkarta, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025
What is the market capitalization of Nkarta, Inc. - Common Stock?
The market capitalization of Nkarta, Inc. - Common Stock is 114.51M
How many shares of Nkarta, Inc. - Common Stock are outstanding?
Nkarta, Inc. - Common Stock has 48.93M shares outstanding.